2012
DOI: 10.1201/b12154
|View full text |Cite
|
Sign up to set email alerts
|

Nanostructures and Nanoconstructions based on DNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 13 publications
(21 citation statements)
references
References 2 publications
1
20
0
Order By: Relevance
“…The stability of "rigid" DNA particles depends on the properties of the nanobridges, not on the osmotic pressure of solution [15]. The result of the AFM studies of the "rigid" DNA particles allows one to perform some important evaluations [3]. It was confirmed that one "rigid" particle contains 1.6 l0 4 ds DNA molecules, the molecular mass of one DNA "rigid" particle is equal to (1.0-1.2) 10 10 Da.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The stability of "rigid" DNA particles depends on the properties of the nanobridges, not on the osmotic pressure of solution [15]. The result of the AFM studies of the "rigid" DNA particles allows one to perform some important evaluations [3]. It was confirmed that one "rigid" particle contains 1.6 l0 4 ds DNA molecules, the molecular mass of one DNA "rigid" particle is equal to (1.0-1.2) 10 10 Da.…”
Section: Resultsmentioning
confidence: 99%
“…In this case, the twist angle between layers (~ 0.1 [4]) may vanish, which is equivalent to unwinding of the cholesteric structure of the dispersion [7]. Moreover, one can suppose that nano-Au with the size comparable to the distance [3,4] between DNA molecules in quasinematic layers can diffuse between these molecules (Fig. 2).…”
Section: Changes In CD Spectra Caused By the Doping Of Dna Clcd Partimentioning
confidence: 99%
See 2 more Smart Citations
“…The mobile and inexpensive device is intended for use in a biosensor analytical system for rapid determination of biologically active compounds in liquids to solve practical problems of clinic medicine and pharmacology.We develop optical biosensor analytical systems, in which "liquid" particles of the cholesteric liquid-crystalline dispersion (CLCD) of DNA are used as a biosensing unit, and a portable dichrometer registers changes of the circular dichroism (CD) signal generated with the DNA biosensing unit during its interaction with a defined biologically active compound (BAC) [1]. DNA biosensing units exhibit anomalously large optical activity in the CD spectrum in an absorption band of DNA nitrogen bases (chromophores) at 270 nm, the magnitude of which is stable and acts as a convenient "quality" criterion of prepared DNA CLCD particles.…”
mentioning
confidence: 99%